This Article  • References  • Full text PDF  • Reply to article  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Citing articles on Web of Science (68)  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

Mary A. Johnson, PhD; Sergiu Marcus, MD, PhD; Michael J. Elman, MD; Thomas J. McPhee, MD

Arch Ophthalmol. 1988;106(3):348-352.

Abstract
• Electroretinograms (ERGs) were measured in 15 patients with central retinal vein occlusion (CRVO). Seven of the patients had neovascularization of the iris (NVI) at the time of testing, and two developed NVI within one month of testing; six did not have NVI or any other form of neovascularization (NV) and were no longer considered to be at risk for NV from their present occlusion. The ERGs were recorded as a function of the stimulus intensity and to a 30-Hz flickering stimulus. A Naka-Rushton-type function was fit to b-wave amplitudes, measured as a function of stimulus intensity, to evaluate changes in ERG amplitude and sensitivity. Compared with eyes in the no-NV group, eyes developing NVI had significantly reduced ERG sensitivity and amplitudes. The distributions of sensitivity values in these two groups did not overlap. All of the eyes with NV showed large a- and b-wave and 30-Hz implicit time delays, but only one eye had a b/ a-wave amplitude ratio close to or less than 1. A comparison of ERG sensitivity, amplitude data, and flicker timing data with retinal fluorescein angiography in a two-alternative forced-choice analysis showed that ERG sensitivity and amplitude loss were better than retinal fluorescein angiography at discriminating eyes with CRVO and NVI from eyes with CRVO without NVI.

Author Affiliations
From the Wilmer Ophthalmological Institute, The Johns Hopkins University School of Medicine, Baltimore.

Footnotes
Accepted for publication Sept 4,1987.

Reprint requests to Wilmer Ophthalmological Institute, Room B-27, The Johns Hopkins Hospital, 601 N Broadway, Baltimore, MD 21205 (Dr Johnson).

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

A Targeted Inhibitor of the Alternative Complement Pathway Reduces Angiogenesis in a Mouse Model of Age-Related Macular Degeneration
Rohrer et al.
IOVS 2009;50:3056-3064.
ABSTRACT | FULL TEXT  

Multifocal Electroretinographic Features of Central Retinal Vein Occlusion
Dolan et al.
IOVS 2003;44:4954-4959.
ABSTRACT | FULL TEXT  

Altered Retinal Function and Structure after Chronic Placental Insufficiency
Bui et al.
IOVS 2002;43:805-812.
ABSTRACT | FULL TEXT  

Photopic 30 Hz flicker ERG as a predictor for rubeosis in central retinal vein occlusion
Larsson and Andreasson
Br J Ophthalmol 2001;85:683-685.
ABSTRACT | FULL TEXT  

Central retinal vein occlusion: what's the story?
WILLIAMSON
Br J Ophthalmol 1997;81:698-704.
FULL TEXT  

The ERG Is Alive and Well
Marmor
Arch Ophthalmol 1995;113:1371-1372.
ABSTRACT  

Predicting Outcome in Central Retinal Vein Occlusion Using the Flicker Electroretinogram
Severns and Johnson
Arch Ophthalmol 1993;111:1123-1130.
ABSTRACT  

Electroretinographic Findings in Iris Neovascularization due to Acute Central Retinal Vein Occlusion
Johnson and McPhee
Arch Ophthalmol 1993;111:806-814.
ABSTRACT  

Standardized Full-Field Electroretinography: Normal Values and Their Variation With Age
Birch and Anderson
Arch Ophthalmol 1992;110:1571-1576.
ABSTRACT  

Correlation of Electroretinographic Findings and Peripheral Retinal Nonperfusion in Patients With Sickle Cell Retinopathy
Peachey et al.
Arch Ophthalmol 1990;108:1106-1109.
ABSTRACT  

Electroretinographic Findings in Fellow Eyes of Patients With Central Retinal Vein Occlusion
Sakaue et al.
Arch Ophthalmol 1989;107:1459-1462.
ABSTRACT  

The Focal Electroretinogram in Fellow Eyes of Patients With Idiopathic Macular Holes
Birch et al.
Arch Ophthalmol 1988;106:1558-1563.
ABSTRACT